Contract and third-party manufacturing
Manufacturer matching for buyer-led programmes, private-label requirements and commercial supply, from technical assessment through production follow-up.
Philippines
Pharmaceutical Manufacturing & Supply for Philippines
KOIT coordinates pharmaceutical sourcing, contract and neutral-code manufacturing, institutional supply and regulatory documentation for established partners serving the Philippine market.
Manufacturing & sourcing
Contract manufacturing and pharmaceutical sourcing from India
We connect Philippine requirements with qualified Indian manufacturers selected for the product, dosage form, documentation needs, quality standard and commercial fit.
Finished pharmaceutical products
Generic medicines and finished dosage forms sourced against the required molecule, strength, dosage form, presentation and target-market needs.
Documentation review
Early coordination of available manufacturer, quality and product documents before a buyer advances a programme commercially.
Quality-standard alignment
WHO-GMP and EU-GMP-capable manufacturers considered where applicable, without implying automatic Philippine FDA acceptance.
Institutional supply
Government procurement and institutional pharmaceutical supply
Philippine institutional procurement can involve PhilGEPS registration, procurement eligibility, local participation, exact product specifications, documentary submissions and defined delivery obligations. The applicable route depends on the procuring entity and opportunity.
KOIT supports qualified local participants by coordinating manufacturing capacity, technical documents, commercial inputs and supply planning with the selected foreign manufacturer.
KOIT is not an approved Philippine government supplier, does not act as the local bidder or importer of record, and does not guarantee procurement eligibility or tender awards.
What we coordinate
- Product and manufacturer capability review
- Specification and presentation alignment
- Available technical and commercial documentation
- Production capacity and delivery planning
- Communication between local and overseas stakeholders
Regulatory coordination
Philippine FDA registration and documentation coordination
KOIT coordinates with the local applicant, importer and regulatory advisers so manufacturer and product documents can be prepared against the applicable Philippine FDA pathway.
Depending on the arrangement, relevant considerations may include a locally licensed importer or establishment, a License to Operate (LTO), a Certificate of Product Registration (CPR), foreign-manufacturer GMP documentation, product-specific registration requirements and import documentation.
Requirements depend on the product, manufacturer, applicant and current Philippine FDA rules. KOIT does not act as the regulator, registration holder or importer of record, and cannot guarantee registration or approval.
Product registration and regulatory supportImportant distinction
WHO-GMP or EU-GMP status can support assessment of manufacturing quality, but neither automatically confers Philippine FDA acceptance, an LTO, a CPR or permission to import a product.
Buyer-specific programmes
Neutral-code manufacturing
KOIT coordinates buyer-specific manufacturing, packaging and supply requirements where a neutral-code structure is commercially appropriate. Product specifications, labelling, documentation access and traceability are aligned with the buyer, manufacturer and relevant regulatory stakeholders.
Neutral-code manufacturing is a commercial arrangement. It does not bypass Philippine registration, licensing, labelling, import or other local regulatory requirements.
Explore neutral-code manufacturingInternational trade
Merchant Trade Transactions for Philippine supply
Where the manufacturer, commercial counterparty and Philippine buyer sit in different jurisdictions, an MTT structure may support a coordinated cross-border pharmaceutical transaction.
KOIT coordinates the commercial, documentation and logistics interfaces between the parties. Suitability depends on the transaction, product, destination requirements and the responsibilities of the licensed local participants.
Merchant Trade Transactions
Capability network
Manufacturer network and therapeutic coverage
Our network spans qualified manufacturers with capabilities across finished dosage forms and a range of therapeutic categories. Manufacturer selection remains specific to each product, quality requirement and Philippine commercial or regulatory need.
OncologyCritical CareRespiratoryCardiovascularCentral Nervous SystemWomen’s HealthGastroenterologyAnti-InfectivesNutraceuticalsDermatology
Who we work with
Partners across the Philippine pharmaceutical supply chain
Pharmaceutical importers
Pharmaceutical distributors
Institutional buyers
Pharmaceutical companies
Procurement partners
Healthcare supply-chain businesses
Process
A clear five-step coordination process
One commercial coordination channel from the initial requirement through documentation, regulatory alignment and supply follow-up.
- 1
Requirement Assessment
- 2
Manufacturer Identification
- 3
Commercial & Documentation Review
- 4
Regulatory Coordination
- 5
Supply Follow-Up
FAQs
Questions from Philippine pharmaceutical partners
Can KOIT coordinate Philippines pharmaceutical imports from India?+
Yes. KOIT can identify suitable Indian manufacturers for generic medicines and finished pharmaceutical products, coordinate commercial discussions, and gather available product and manufacturer documentation for pharmaceutical imports into the Philippines. The Philippine importer and its regulatory advisers remain responsible for local eligibility, licensing, FDA registration and import requirements.
Does KOIT coordinate contract manufacturing for Philippine pharmaceutical companies?+
Yes. We coordinate contract and third-party manufacturing programs with qualified manufacturing partners. The scope can include product matching, technical review, packaging requirements, documentation, commercial terms and supply follow-up, subject to the manufacturer’s capabilities and Philippine requirements.
Does KOIT guarantee Philippine FDA registration or approval?+
No. KOIT does not grant or guarantee registration or regulatory approval. We coordinate manufacturer and product documentation with the local applicant, importer and regulatory partners. Decisions remain with the Philippine FDA under the rules applicable to the product and applicant.
What foreign manufacturer documentation may be needed?+
Requirements vary, but may include GMP evidence, manufacturing licences, product specifications, certificates of analysis, stability data, a Certificate of Pharmaceutical Product and dossier materials. The exact set depends on the product, manufacturer, applicant and current Philippine FDA requirements.
Does WHO-GMP or EU-GMP mean a product is approved in the Philippines?+
No. WHO-GMP and EU-GMP relate to manufacturing quality standards and do not equal Philippine FDA approval, an LTO, product registration or import authorisation. Each product and supply arrangement must meet the applicable Philippine requirements.
Can KOIT support PhilGEPS pharmaceutical procurement opportunities?+
KOIT can support established local participants pursuing institutional supply or PhilGEPS pharmaceutical procurement opportunities by coordinating manufacturer capacity, product specifications, commercial documentation and supply planning. KOIT is not an approved Philippine government supplier and does not guarantee PhilGEPS eligibility, procurement qualification or tender awards.
Philippines enquiry
Share your pharmaceutical requirement
Tell us the product, target market and support you require. KOIT will review the details and respond directly.
Philippines enquiries
Discuss your pharmaceutical manufacturing or supply requirement.
Share the product, dosage form, expected volume, target market and current regulatory status. KOIT will assess manufacturer and coordination options for your programme.